Using CT to assess heart tissue health
Official title: CT-based Myocardial Characterization
Run by IRCCS San Raffaele · NCT06029400 · Data updated 2026-11-12
This study is testing if advanced heart scans can help doctors see heart tissue damage and changes in patients with different heart problems who need a CT scan.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 2200 (estimated) |
| Sponsor | IRCCS San Raffaele Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | October 12, 2020 |
| Main results expected | October 12, 2032 |
| Study ends | October 12, 2032 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT06029400 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with specific cardiovascular conditions requiring cardiac CT.
✕Probably not a fit
Patients under 18, pregnant or breastfeeding women, and those with contraindications to iodinated contrast agents may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify myocardial fibrosis and assess myocardial scar and extracellular matrix remodeling using advanced cardiac CT techniques. It focuses on patients with various cardiovascular conditions who require a cardiac CT for clinical indications such as stable angina, heart failure, or arrhythmias. The study seeks to provide a non-invasive alternative to cardiac magnetic resonance imaging, which has limitations in certain patient populations and acute settings.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and management of cardiovascular diseases by providing a reliable non-invasive imaging option.
How similar studies have gone: While cardiac CT is a well-established imaging modality, this specific approach to myocardial characterization is relatively novel and may offer new insights into cardiovascular disease management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age ≥ 18 years; * no contraindication to cCT * signed informed consent * clinical indication to cCT for the following reason: stable angina, heart failure, atrial/ ventricular arrhythmias, acute chest pain with need of "triple-rule-out" scan, planning of valvular repair/substitution, structural and infiltrative cardiomyopathy, new onset ECG alteration, troponin increase. Exclusion Criteria: * age \< 18 years * pregnancy and/or breastfeeding * contraindications to iodinated contrast agent administration or impaired renal function (eGFR ≤ 30 mL/min); * inability to sustain a brief breath hold (5 seconds)
Where it's running
-
IRCCS San Raffaele
Milan, Italy Recruiting
Study contacts
- Study coordinator: Antonio Esposito
- Email: esposito.antonio@hsr.it
- Phone: 02 2643 6102
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.